Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Traditional Chinese medicine (TCM) plant polysaccharide activity testing is a specialized analytical service that evaluates the structural characteristics and bioactive properties of polysaccharides extracted from medicinal plants and fungi. Our comprehensive testing platform combines structural characterization, in vitro bioactivity assays, and in vivo pharmacological evaluation to support quality control, product development, and scientific research. With advanced instrumentation and standardized protocols, we deliver accurate, reproducible data for polysaccharide-based pharmaceuticals, functional foods, and health supplements.

Technical Overview

Polysaccharides are among the most important bioactive macromolecules found in traditional Chinese medicine plants and medicinal fungi. Composed of monosaccharide units joined by glycosidic bonds, these natural polymers exhibit a wide spectrum of pharmacological activities, including immunomodulation, antioxidant protection, hypoglycemic effects, antitumor activity, anti-inflammatory action, hepatoprotection, and gut microbiota modulation. Unlike small-molecule active ingredients, the biological activity of polysaccharides is governed by their complex structures, including molecular weight distribution, monosaccharide composition, glycosidic linkage patterns, degree of branching, and chain conformation.

Activity testing of TCM plant polysaccharides integrates structural analysis with functional evaluation. Because structure-activity relationships are central to polysaccharide pharmacology, a rigorous testing program must characterize both the chemical fingerprint and the biological performance of each sample. Our testing services follow established pharmacopoeial standards, peer-reviewed methodologies, and Good Laboratory Practice (GLP) principles to ensure data integrity and regulatory compliance. Typical analytical workflows span crude polysaccharide screening, purified fraction characterization, in vitro cell-based activity assays, and in vivo animal model validation.

Testing Samples

Root and Rhizome Polysaccharides

Roots and rhizomes are the most common medicinal parts used in TCM and represent a major source of bioactive polysaccharides. Accepted sample types include crude drug powders, water extracts, decolorized crude polysaccharides, and purified fractions from plants such as Astragalus membranaceus, Panax ginseng, Codonopsis pilosula, Angelica sinensis, Atractylodes macrocephala, Ophiopogon japonicus, and Polygonatum sibiricum. Both neutral polysaccharides and acidic heteropolysaccharides containing uronic acid residues can be analyzed.

Fruit, Seed, and Flower Polysaccharides

Fruit-derived polysaccharides, particularly from Lycium barbarum (goji berry), Ziziphus jujuba (jujube), and Schisandra chinensis, are widely used in functional foods and herbal formulations. Pectic polysaccharides, arabinogalactans, and glucans isolated from these materials can be submitted as fresh materials, dried powders, concentrates, or freeze-dried extracts. Flower polysaccharides from Chrysanthemum, Lonicera, and Sophora species are also within our testing scope.

Medicinal Fungal Polysaccharides

Fungal polysaccharides constitute a distinct category with characteristic beta-glucan structures and notable immunomodulatory activity. We accept samples derived from Ganoderma lucidum (reishi), Cordyceps sinensis and Cordyceps militaris, Poria cocos, Hericium erinaceus, Lentinula edodes (shiitake), and Tremella fuciformis. Both fruiting body and fermentation-derived mycelial polysaccharides can be evaluated, including sulfated and acetylated derivatives.

Formulated Products and Process Intermediates

Finished products such as oral liquids, capsules, granules, and powder blends containing TCM polysaccharides can be tested for activity retention after processing. Intermediate samples from extraction, ethanol precipitation, deproteinization, and column purification steps are accepted to support process development and batch consistency studies.

Testing Items

Our polysaccharide activity testing portfolio covers four dimensions: physicochemical characterization, structural elucidation, in vitro bioactivity, and in vivo efficacy evaluation. Clients may select individual test items or commission an integrated structure-activity relationship study.

  • Total polysaccharide content determination by phenol-sulfuric acid method

  • Uronic acid content by carbazole or meta-hydroxydiphenyl method

  • Protein residue quantification by Bradford or Kjeldahl method

  • Molecular weight distribution by HPGPC and SEC-MALLS

  • Monosaccharide composition profiling by PMP-HPLC or GC-MS

  • Glycosidic linkage analysis by methylation coupled with GC-MS

  • Functional group identification by FT-IR spectroscopy

  • Chain conformation and triple helix structure by Congo red assay and NMR

  • In vitro antioxidant activity (DPPH, ABTS, hydroxyl radical, superoxide anion, FRAP)

  • Immunomodulatory activity (macrophage phagocytosis, nitric oxide release, splenocyte proliferation, cytokine secretion)

  • Hypoglycemic activity (alpha-glucosidase and alpha-amylase inhibition, glucose uptake assays)

  • Antitumor cytotoxicity screening against selected cancer cell lines

  • Anti-inflammatory activity in LPS-stimulated cell models

  • Prebiotic activity and gut microbiota fermentation evaluation

  • Endotoxin and microbial limit testing for safety assessment

Testing Methods

Extraction and Purification Support

Prior to activity testing, samples undergo standardized preparation. Hot water extraction, ultrasonic-assisted extraction, or enzymatic hydrolysis is employed depending on sample matrix. Deproteinization by Sevag method or trichloroacetic acid treatment, decolorization, ethanol fractional precipitation, and dialysis are performed to obtain polysaccharide fractions suitable for analysis. Gradient purification using DEAE-cellulose anion exchange chromatography followed by Sephadex or Sepharose gel filtration yields homogeneous fractions for structural studies.

Structural Characterization

Molecular weight and homogeneity are determined by high-performance gel permeation chromatography (HPGPC) coupled with multi-angle laser light scattering (SEC-MALLS) and refractive index detection. Monosaccharide composition is quantified after trifluoroacetic acid hydrolysis and PMP pre-column derivatization using HPLC with UV detection, or after alditol acetate derivatization by GC-MS. Linkage patterns are established through methylation analysis. FT-IR confirms characteristic glycosidic bonds and functional groups, while one- and two-dimensional NMR spectroscopy (COSY, HSQC, HMBC) resolves anomeric configurations and residue sequences. Congo red testing and circular dichroism assess triple helix conformation where relevant.

In Vitro Bioactivity Assays

Antioxidant capacity is measured through multiple complementary radical scavenging and reducing power assays to capture both hydrogen atom transfer and single electron transfer mechanisms. Immunomodulatory activity is evaluated using RAW264.7 murine macrophages, measuring phagocytic uptake, nitric oxide production, and cytokine release (TNF-alpha, IL-6, IL-1beta) by ELISA, with LPS as positive control and endotoxin contamination excluded by polymyxin B verification. Lymphocyte proliferation is assessed by CCK-8 or MTT assay. Enzyme inhibition models quantify hypoglycemic potential, while glucose consumption in insulin-resistant HepG2 or L6 cells provides mechanistic insight. All cell-based assays include positive controls, negative controls, and cytotoxicity verification to confirm that observed activity is not attributable to cell death.

In Vivo Pharmacological Evaluation

Animal studies validate in vitro findings under physiological conditions. Established models include cyclophosphamide-induced immunosuppression in mice for immunomodulatory assessment, streptozotocin or high-fat-diet-induced diabetic models for hypoglycemic evaluation, and D-galactose or SAMP8 models for anti-aging and antioxidant studies in vivo. Endpoints encompass organ indices, serum cytokine panels, oxidative stress markers (SOD, GSH-Px, MDA), histopathological examination, and gut microbiota profiling by 16S rRNA sequencing. All animal procedures follow ethical committee approval and applicable animal welfare regulations.

Applications

Polysaccharide activity testing supports multiple stages of product development and scientific research:

  • Quality control and batch consistency verification for TCM polysaccharide raw materials and extracts

  • Establishment of structure-activity relationships to guide extraction and purification process optimization

  • Efficacy substantiation for functional foods, health foods, and dietary supplements in registration filings

  • Preclinical data generation for botanical drug and natural product development programs

  • Comparative activity studies between wild and cultivated materials or between geographic origins

  • Screening of fermentation-engineered polysaccharides and modified derivatives, including sulfated and acetylated products

  • Supporting data for peer-reviewed publications, patents, and technology transfer documentation

FAQ

How much sample is required for a complete testing package?

For structural characterization combined with in vitro activity screening, approximately 200 to 500 milligrams of purified polysaccharide is typically sufficient. If purification from raw material is required, 50 to 200 grams of dried plant material is recommended. In vivo studies require larger quantities, and our technical team will provide a customized estimate based on the study design.

Why must endotoxin contamination be controlled in immunomodulatory testing?

Bacterial endotoxin (lipopolysaccharide) is a potent immune stimulant that can generate false-positive results in macrophage and cytokine assays. We screen polysaccharide samples using the limulus amebocyte lysate (LAL) assay and apply polymyxin B neutralization controls to ensure that observed immunomodulatory activity genuinely originates from the plant polysaccharide.

What is the typical turnaround time?

Standard physicochemical and in vitro assays are generally completed within 10 to 15 working days. Structural elucidation including NMR and methylation analysis requires approximately 20 to 30 working days. In vivo pharmacological studies depend on the model and duration, typically ranging from 4 to 12 weeks.

Which standards and guidelines do the tests follow?

Testing protocols reference the Chinese Pharmacopoeia, AOAC International methods, and peer-reviewed methodologies published in recognized journals of carbohydrate chemistry and pharmacology. Cell-based assays follow standardized in vitro pharmacological practices, and animal studies comply with institutional animal care and use committee requirements.

Can crude polysaccharide mixtures be tested, or is purification required?

Crude polysaccharides can be screened for preliminary activity, and this approach is common during early-stage material evaluation. However, for structure-activity relationship studies, publication-grade data, or regulatory submissions, purification to homogeneity followed by comprehensive structural characterization is strongly recommended, as activity in crude mixtures may be influenced by co-existing proteins, polyphenols, or pigments.